TMEFF2 and prostate carcinoma: TMEFF2 has also been identified in human testes, shown to prevent PDGF-AA-induced cellular proliferation, to be upregulated by androgen in some prostate cancer cells, and to have oncogenic and onco-suppressive actions depending on the tissue/cancer type context [44,45].